A detailed history of Susquehanna Fundamental Investments, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Susquehanna Fundamental Investments, LLC holds 163,025 shares of ANNX stock, worth $841,209. This represents 0.02% of its overall portfolio holdings.

Number of Shares
163,025
Previous 33,570 385.63%
Holding current value
$841,209
Previous $241 Million 231.88%
% of portfolio
0.02%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$4.33 - $6.79 $560,540 - $878,999
129,455 Added 385.63%
163,025 $799 Million
Q1 2024

May 07, 2024

BUY
$4.03 - $7.81 $135,287 - $262,181
33,570 New
33,570 $241 Million
Q1 2021

May 17, 2021

SELL
$22.0 - $35.01 $386,518 - $615,090
-17,569 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$20.81 - $30.55 $92,708 - $136,100
-4,455 Reduced 20.23%
17,569 $440,000
Q3 2020

Nov 16, 2020

BUY
$17.5 - $30.23 $385,420 - $665,785
22,024 New
22,024 $666,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $246M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.